Endovascular Versus Open Repair of the Common Femoral Artery
NCT: NCT01353651 · COMPLETED
Brief Summary
Even though the indication for endovascular therapy has been enlarged, open repair of common femoral artery is still considered as the treatment of choice. A recent pilot study showed that endovascular repair of the CFA seems to be a safe technique of revascularization with acceptable initial results at 12 months (Azema et al, Eur J Vasc Endovasc Surg, 2011, in press). TECCO, a French randomized and controlled trial, has been set up to compare open and endovascular procedures for the treatment of CFA atherosclerotic lesions.
Frequently Asked Questions
What is Endovascular Versus Open Repair of the Common Femoral Artery?
Endovascular Versus Open Repair of the Common Femoral Artery is a clinical trial registered under NCT01353651. Current status: COMPLETED.
What is the status of NCT01353651?
The current status of NCT01353651 (Endovascular Versus Open Repair of the Common Femoral Artery) is: COMPLETED.
When did Endovascular Versus Open Repair of the Common Femoral Artery start?
Endovascular Versus Open Repair of the Common Femoral Artery started on 2011-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.